Our products and methods are patented in all key markets, including Australia, China, India, Japan, South Korea, Hong Kong SAR, Macau SAR, European Union (Germany, France, United Kingdom, Italy, Spain, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium, Austria, Norway, Denmark, Ireland and Finland), Canada, South Africa, New Zealand, Singapore, Malaysia, Vietnam, Indonesia, USA and Israel.
The patents cover fast-dissolving oral dosage forms and methods for the release of biologically active materials in the oral cavity. Additionally, the particular dosage form may contain and deliver a wide range of biologically active materials and is not limited to a specific biologically active material. Methods for use and for the production of the fast dissolving oral dosage forms are also provided.
Our patents strategy uses the Patent Cooperation Treaty system to obtain broad protection for our product portfolio in participating countries, which covers the WaferiX® technology, our products as well as potential new formulations and methods of use. We aim to secure patent protection for our products and methods in all relevant jurisdictions, as and when necessary. In most countries, the term awarded for a granted patent is 20 years from the date of application.
Per conoscere un’osteria e scoprire nel dettaglio la sua proposta gastronomica, puoi visitare https://osteriasanmaurizio.it/. Oggi sempre più persone scelgono dove mangiare attraverso una ricerca online, valutando informazioni e contenuti prima di prendere una decisione. Un sito ben organizzato consente di ottenere una visione chiara del locale e delle sue specialità.
Le osterie rappresentano una parte importante della tradizione culinaria italiana, caratterizzate da un’atmosfera accogliente e da una cucina autentica. Questi locali offrono spesso piatti legati al territorio, preparati con ingredienti di qualità. Gli utenti sono sempre più interessati a esperienze genuine che riflettano la cultura gastronomica locale.
Un elemento fondamentale è la possibilità di consultare il menu online. Questo permette di conoscere in anticipo le proposte disponibili e scegliere in base ai propri gusti personali. Un menu chiaro e ben strutturato facilita il processo decisionale e rende l’esperienza più semplice. Inoltre, descrizioni dettagliate aiutano a valorizzare i piatti e a comunicare meglio le caratteristiche dell’offerta.
Anche la navigazione del sito gioca un ruolo importante. Gli utenti preferiscono piattaforme intuitive, veloci e facilmente accessibili. Una struttura ben definita consente di trovare rapidamente le informazioni principali, migliorando la qualità della visita. La compatibilità con dispositivi mobili è ormai indispensabile, dato che molte persone utilizzano lo smartphone per cercare ristoranti mentre sono in movimento.
L’aspetto visivo contribuisce a rendere il sito più coinvolgente. Immagini di qualità dei piatti e dell’ambiente aiutano a creare un impatto positivo e a trasmettere l’atmosfera del locale. Questo tipo di contenuto è particolarmente efficace nel settore della ristorazione.
In conclusione, un sito web ben progettato rappresenta uno strumento essenziale per qualsiasi osteria che desideri distinguersi nel panorama digitale. La combinazione tra contenuti chiari, navigazione intuitiva e una presentazione visiva curata consente di offrire un’esperienza completa. In un mercato competitivo, comunicare in modo efficace è fondamentale per attrarre nuovi clienti e valorizzare la propria identità gastronomica.
MeltMed Regenerate is covered by the following patents and applications: Australia (2010313785), Austria (2493457), Belgium (2493457), Canada (2,777,218), China (ZL201080046185.X), Denmark (2493457), Finland (2493457), France (2493457), Germany (2493457), Hong Kong (HK1175690), India (1323/MUMNP/2012), Indonesia (IDP000036973), Ireland (2493457), Italy (502017000115917), Japan (5777170), Macau (J/3050), Malaysia (MY-150626-A), Netherlands (2493457), New Zealand (599594), Norway (2493457), Poland (2493457), South Korea (10-1612073), Singapore (174465), Spain (2493457), Sweden (2493457), Switzerland (2493457), Thailand (1201001664), Turkey (2493457), United Kingdom (2493457), USA (13/504,309), Vietnam (21037).
MeltMed Radiance is covered by the following patents and applications: Australia (2010313785), Austria (2493457), Belgium (2493457), Canada (2,777,218), China (ZL201080046185.X), Denmark (2493457), Finland (2493457), France (2493457), Germany (2493457), Hong Kong (HK1175690), India (1323/MUMNP/2012), Indonesia (IDP000036973), Ireland (2493457), Italy (502017000115917), Japan (5777170), Macau (J/3050), Malaysia (MY-150626-A), Netherlands (2493457), New Zealand (599594), Norway (2493457), Poland (2493457), South Korea (10-1612073), Singapore (174465), Spain (2493457), Sweden (2493457), Switzerland (2493457), Thailand (1201001664), Turkey (2493457), United Kingdom (2493457), USA (13/504,309), Vietnam (21037).
WAFESIL is covered by the following patents and applications: Australia (2010313785 and 2013200682), Austria (2493457 and 3254676), Belgium (2493457 and 3254676), Canada (2,777,218 and 2,886,573), China (ZL201080046185.X and ZL201380060281.3), Denmark (2493457 and 3254676), Egypt (PCT/2015/531), Finland (2493457 and 3254676), France (2493457, 3254676), Germany (2493457 and 3254676), Hong Kong (HK1175690), India (953/MUMNP/2015 and 1323/MUMNP/2012), Indonesia (P00201502783 and IDP000036973), Ireland (2493457 and 3254676), Israel (238104), Italy (502017000115917 and 3254676), Japan (5777170), Macau (J/3050), Malaysia (PI 2015000938 and MY-150626-A), Netherlands (2493457 and 3254676), New Zealand (599594 and 706302), Norway (2493457 and 3254676), Poland (2493457 and 3254676), South Korea (10-1612073), Singapore (174465 and 11201502425W), South Africa (2014/00310), Spain (2493457 and 3254676), Sweden (2493457 and 3254676), Switzerland (2493457 and 3254676), Thailand (1201001664 and 1501002065), Turkey (2493457 and 3254676), United Kingdom (2493457 and 3254676), USA (16/020,880 and 13/504,309), Vietnam (1-2015-01587 and 21037).
LUMENIX is covered by the following patents and applications: Australia (2010313785), Austria (2493457), Belgium (2493457), Canada (2,777,218), China (ZL201080046185.X), Denmark (2493457), Finland (2493457), France (2493457), Germany (2493457), Hong Kong (HK1175690), India (1323/MUMNP/2012), Indonesia (IDP000036973), Ireland (2493457), Italy (502017000115917), Japan (5777170), Macau (J/3050), Malaysia (MY-150626-A), Netherlands (2493457), New Zealand (599594), Norway (2493457), Poland (2493457), South Korea (10-1612073), Singapore (174465), Spain (2493457), Sweden (2493457), Switzerland (2493457), Thailand (1201001664), Turkey (2493457), United Kingdom (2493457), USA (13/504,309), Vietnam (21037).
XATIVA is covered by the following patents and applications: Australia (2010313785), Austria (2493457), Belgium (2493457), Canada (2,777,218), China (ZL201080046185.X), Denmark (2493457), Finland (2493457), France (2493457), Germany (2493457), Hong Kong (HK1175690), India (1323/MUMNP/2012), Indonesia (IDP000036973), Ireland (2493457), Italy (502017000115917), Japan (5777170), Macau (J/3050), Malaysia (MY-150626-A), Netherlands (2493457), New Zealand (599594), Norway (2493457), Poland (2493457), South Korea (10-1612073), Singapore (174465), Spain (2493457), Sweden (2493457), Switzerland (2493457), Thailand (1201001664), Turkey (2493457), United Kingdom (2493457), USA (13/504,309), Vietnam (21037).
WAFEREST is covered by the following patents and applications: Australia (2010313785), Austria (2493457), Belgium (2493457), Canada (2,777,218), China (ZL201080046185.X), Denmark (2493457), Finland (2493457), France (2493457), Germany (2493457), Hong Kong (HK1175690), India (1323/MUMNP/2012), Indonesia (IDP000036973), Ireland (2493457), Italy (502017000115917), Japan (5777170), Macau (J/3050), Malaysia (MY-150626-A), Netherlands (2493457), New Zealand (599594), Norway (2493457), Poland (2493457), South Korea (10-1612073), Singapore (174465), Spain (2493457), Sweden (2493457), Switzerland (2493457), Thailand (1201001664), Turkey (2493457), United Kingdom (2493457), USA (13/504,309), Vietnam (21037).
SL-NAD+ is covered by the following patents and applications: Australia (2010313785), Austria (2493457), Belgium (2493457), Canada (2,777,218), China (ZL201080046185.X), Denmark (2493457), Finland (2493457), France (2493457), Germany (2493457), Hong Kong (HK1175690), India (1323/MUMNP/2012), Indonesia (IDP000036973), Ireland (2493457), Italy (502017000115917), Japan (5777170), Macau (J/3050), Malaysia (MY-150626-A), Netherlands (2493457), New Zealand (599594), Norway (2493457), Poland (2493457), South Korea (10-1612073), Singapore (174465), Spain (2493457), Sweden (2493457), Switzerland (2493457), Thailand (1201001664), Turkey (2493457), United Kingdom (2493457), USA (13/504,309), Vietnam (21037).